Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival

Pediatric Pulmonary hypertension (PAH) is a heterogeneous disease, characterized by sustained elevation of pulmonary arterial pressures and death from right ventricular failure. Given the extremely high burden of morbidity and mortality associated with this disease, and the risk of the invasive procedures required for diagnostics, novel biomarkers for this disease would be beneficial. In this episode, we meet Early Career Investigator, Dr. Megan Griffiths from Johns Hopkins University, School of Medicine, who examined two candidate IGF axis proteins as potential predictors of PAH severity. 

Hosted on Acast. See acast.com/privacy for more information.

More from Pediatric Research Podcast

  1. 11:15What's hot in Endocrinology? Apr 24, 2024
  2. 13:18Conversation With Pediatric Researchers Cynthia Bearer and Eleanor MolloyMar 22, 2024
  3. 13:43Conversation with Linda de VriesFeb 06, 2024
  4. 13:46Global climate change: the defining issue of our time for our children’s healthJan 16, 2024
  5. 13:24Predicting functional and quality-of-life outcomes following pediatric sepsis.Nov 29, 2023
  6. 17:42Conversation with Dr. Maximo VentoNov 20, 2023
  7. 13:01The association of placental pathology and neurodevelopmental outcomes in patients with neonatal encephalopathyNov 02, 2023
  8. 11:59Do Bayley trajectories predict school-readiness better than single assessments in formerly very preterm infants?Oct 23, 2023
  9. 11:19Novel metrics to characterise the temporal lobe of very preterm infants.Sep 11, 2023
  10. 12:13Trends in fetal and neonatal outcomes during the COVID-19 pandemicAug 23, 2023